Stock Movers: AT&T Spectrum Deal, Eli Lilly Obesity Pill, AMD & IBM Quantum Partnership

AT&T Acquires Spectrum Licenses

• 📞 AT&T is set to purchase spectrum licenses from EchoStar for approximately $23 billion.
• 🚀 This acquisition is intended to enhance AT&T's capability to deliver 5G and fiber services across the United States.
• 📰 The deal appears to be a consequence of federal regulators encouraging EchoStar to sell airwaves it had not utilized, as previously reported by Bloomberg.

Eli Lilly's Promising Obesity Pill Trial

• 💊 Eli Lilly's experimental obesity pill demonstrated positive results in its second clinical trial.
• 📈 Patients in this trial achieved an average 9.6% body weight loss.
• 🗓️ The company is on track to file for regulatory approval by the end of the year, with potential market availability in 2026.

AMD and IBM Forge Quantum Computing Partnership

• ⚛️ AMD and IBM are collaborating to develop next-generation computing architectures.
• 💻 This partnership focuses on combining quantum computers with high-performance computing, termed quantum-centric supercomputing.
• 🤝 An initial demonstration showcasing IBM quantum computers working with AMD technologies for hybrid quantum-classical workflows is planned for later this year.
• 📈 Analysts have responded positively, with Truist upgrading AMD to a 'buy' rating and increasing its price target.